+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

The second leading cause of new cancer cases in men worldwide with over two million sufferers in the US alone, prostate cancer is typically a disease that affects older men and is thus on the increase as global life expectancies continue to rise. It is also one of the largest sectors of the pharmaceutical oncology industry. Expertly formulated reports in this section will help you to formulate effective market strategies by answering key questions such as who are the main and key niche players, what are the new drugs and therapies (including vaccines and therapeutic antibodies) in the pipeline, and what are the latest areas of pharmaceutical R&D. Manufacturers will find multiple report options to assist them in assessing competition and market opportunities. Show Less Read more

From
From
From
Global Prostate Cancer Partnering 2010 to 2017 - Product Thumbnail Image

Global Prostate Cancer Partnering 2010 to 2017

  • Report
  • March 2017
  • 150 Pages
From
Global Prostate Cancer Drugs Market 2016-2020 - Product Thumbnail Image

Global Prostate Cancer Drugs Market 2016-2020

  • Report
  • November 2016
  • 91 Pages
From
From
From
From
From
Flutamide (CAS 13311-84-7) Market Research Report 2017 - Product Thumbnail Image

Flutamide (CAS 13311-84-7) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
From
From
From
From
From
From
Global and Chinese Leuprolide Industry - 2017 - Product Thumbnail Image

Global and Chinese Leuprolide Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
Global and Chinese Ozarelix Industry - 2017 - Product Thumbnail Image

Global and Chinese Ozarelix Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
Loading Indicator
adroll